Novartis, an innovative healthcare products company with pharmaceutical treatments for heart disease, high blood pressure, diabetes, parkinson’s, alzheimer’s, infectious disease and cancer.

Feature story

Novartis brings "diabetes to light"

Novartis unites with the International Diabetes Federation (IDF) to raise awareness for diabetes. In recognition of World Diabetes Day on November 14, Novartis lit the global headquarters in blue... more ›

Our products

We want to improve your quality of life.

Latest news

19-Nov-2008
Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline

11-Nov-2008
Rasilez®, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older

29-Oct-2008
Rasilez HCT®, single-pill combination of Rasilez® and diuretic, receives Swiss approval for the treatment of high blood pressure

Investors

SWX Swiss Exchange

NYSE NY Stock Exchange

NOVZn

2007 Results | Info for investors

NVS

2007 Results | Info for investors

USA • Switzerland • Germany • France • United Kingdom

Research Day

Research Day
November 19, 2008
Cambridge, MA, USA

Learn more about the event

Watch the webcast ›
09.00 EST

Research

Novartis is one of the industry’s biggest investors in research.

Learn about research at Novartis

Super Sector Leader

Novartis is the 2008 super sector leader in healthcare for the Dow Jones Sustainability Index (DJSI).

Careers

Novartis careers

Our success depends on the creativity and performance of our associates.

Learn more about working at Novartis